0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Josephine Mollon, MSc; Anthony S. David, MD, FRCPsych; Craig Morgan, MSc, PhD; et al.
JAMA Psychiatry. 2016;73(2):129-138. doi:10.1001/jamapsychiatry.2015.2551.
Includes: Supplemental Content

Invited Commentary | 
Charles F. Reynolds III, MD
JAMA Psychiatry. 2015;72(6):619-620. doi:10.1001/jamapsychiatry.2015.0174.

Original Investigation |  FREE
Robert H. Pietrzak, PhD, MPH; Yen Ying Lim, PhD; Alexander Neumeister, MD; et al.
JAMA Psychiatry. 2015;72(3):284-291. doi:10.1001/jamapsychiatry.2014.2476.

Original Investigation |  FREE
Dimitris N. Kiosses, PhD; Lisa D. Ravdin, PhD; James J. Gross, PhD; et al.
JAMA Psychiatry. 2015;72(1):22-30. doi:10.1001/jamapsychiatry.2014.1305.
Includes: Supplemental Content

Original Investigation |  FREE
Ronald Lautner, MD; Sebastian Palmqvist, MD, PhD; Niklas Mattsson, MD, PhD; et al.
JAMA Psychiatry. 2014;71(10):1183-1191. doi:10.1001/jamapsychiatry.2014.1060.
Includes: Supplemental Content

Original Investigation |  FREE
Mi Ji Lee, MD; Sang Won Seo, MD, PhD; Duk L. Na, MD; et al.
JAMA Psychiatry. 2014;71(4):412-422. doi:10.1001/jamapsychiatry.2013.4506.
Includes: Supplemental Content

Original Investigation |  FREE
Angelina R. Sutin, PhD; Antonio Terracciano, PhD; Yuri Milaneschi, PhD; et al.
JAMA Psychiatry. 2013;70(8):803-811. doi:10.1001/jamapsychiatry.2013.193.
Includes: Supplemental Content

Original Article |  FREE
Peder Buchhave, MD, PhD; Lennart Minthon, MD, PhD; Henrik Zetterberg, MD, PhD; et al.
Arch Gen Psychiatry. 2012;69(1):98-106. doi:10.1001/archgenpsychiatry.2011.155.
Includes: Supplemental Content

Original Article |  FREE
Jesus J. Gomar, PhD; Maria T. Bobes-Bascaran, MA; Concepcion Conejero-Goldberg, MD, PhD; et al.
Arch Gen Psychiatry. 2011;68(9):961-969. doi:10.1001/archgenpsychiatry.2011.96.
Includes: Supplemental Content

Original Article |  FREE
Susanne Erk, MD, PhD; Annika Spottke, MD; Alice Meisen, MA; et al.
Arch Gen Psychiatry. 2011;68(8):845-852. doi:10.1001/archgenpsychiatry.2011.80.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Editorial  | 
Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials
Elizabeth C. Mormino, PhD; Kathryn V. Papp, PhD
JAMA Neurology
Original Investigation  | 
Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change
Anja Soldan, PhD; Corinne Pettigrew, PhD; Qing Cai, MS; et al.
JAMA Neurology
Editorial  | 
Cerebrospinal Biomarkers in Alzheimer Disease—Potential Roles as Markers of Prognosis and Neuroplasticity
Steven T. DeKosky, MD; Todd Golde, MD, PhD
JAMA Neurology
Original Investigation  | 
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh, MD; Gina D’Angelo, PhD; Dan Crimmins, PhD; et al.